Automatic threshold sensitivity adjustment for cardiac rhythm management devices

• US 6,029,086 A
• Filed: 06/15/1998
• Issued: 02/22/2000
• Est. Priority Date: 06/15/1998
• Status: Expired due to Term

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Hartley, Jesse W., Zhu, Qingsheng, Kim, Jungkuk
• Primary Examiner(s): Kamm, William E.
• Assistant Examiner(s): LAYNO, CARL HERNANDZ
• Application Number:
  US09/094,773
• Time in Patent Office: 617 Days
• Field of Search: 609/9, 609/14, 609/17
• US Class Current: 607/9
• CPC Class Codes: A61N 1/365 controlled by a physiological parameter, e.g. heart potential evoked response A61N1/371
• CPC Class Codes: A61N 1/368 comprising more than one electrode co-operating with different heart regions A61N1/3622, A61N1/3627 take precedence
• CPC Class Codes: A61N 1/3704 Circuits specially adapted therefor, e.g. for sensitivity control

Abstract

An implantable cardiac rhythm management device includes a controller adapted to receive digitized electrocardiogram signals from leads placed on or in the heart. The device also incorporates an autosense algorithm which automatically adjusts the sensing threshold dependent upon an average or maximum amplitude of noise detected during a period following a sensed cardiac depolarization. The sensing threshold is automatically set on a beat-to-beat basis at a level such that the signal to noise ratio exceeds a preset value.

Claims

1. An implantable cardiac rhythm management device capable of automatically sensing intrinsic events of a patient'"'"'s heart and having an adjustable sensing threshold, said device including:

(a) a pulse generator;

(b) a controller for controlling activation of the pulse generator;

(c) conduction means for conducting an electrocardiogram signal which includes electrical impulses corresponding to cardiac depolarization and noise;

(d) detecting means coupled to the conduction means for detecting intrinsic events from the signal;

(e) measuring means for at least estimating an amplitude of the noise during a period following detected intrinsic events and memory means for storing the estimated amplitude of noise over a plurality of detected intrinsic events; and

(f) adjusting means for adjusting the sensing threshold dependant upon the amplitude of noise estimated from the detected plurality of intrinsic events.

2. The implantable cardiac rhythm management device as recited in claim 1, further including a discriminating means for discriminating, from the electrocardiogram signal, electrical impulses associated with a tachyrhythmia of the patient'"'"'s heart.

3. The implantable cardiac rhythm management device as recited in claim 1, wherein the amplitude of the noise is measured for a predetermined period of time following detection of cardiac depolarization.

4. The implantable cardiac rhythm management device as recited in claim 1, wherein the measurement of the amplitude of noise is initiated by a detection of cardiac depolarization resulting from an intrinsic event in an atrium of the patient'"'"'s heart.

5. The implantable cardiac rhythm management device as recited in claim 1, wherein the measurement of the amplitude of noise is initiated by a detection of cardiac depolarization resulting from an intrinsic event in a ventricle of the patient'"'"'s heart.

6. The implantable cardiac rhythm management device as recited in claim 1, further including memory means for storing the measured amplitude of noise over a plurality of detected cardiac depolarization and adjusting the sensing threshold dependent upon the measured amplitude of noise corresponding to prior detected cardiac depolarization.

7. The implantable cardiac rhythm management device as recited in claim 1, further including a means for averaging the amplitude over a preset period of time.

8. The implantable cardiac rhythm management device as recited in claim 1, further including means for determining the maximum amplitude of noise over a preset period of time.

9. An implantable cardiac rhythm management device capable of automatically sensing intrinsic events of a patient'"'"'s heart and having an adjustable sensing threshold, said device including:

(a) a pulse generator;

(b) a controller for controlling activation of the pulse generator;

(c) conduction means for conducting electrogram signals including electrical impulses corresponding to cardiac depolarization and noise;

(d) detecting means coupled to said conduction means for detecting deflections in the electrogram signal corresponding to intrinsic cardiac events;

(e) measuring means for measuring at least one of an amplitude of noise, a number of deflections in the signal over a predetermined period, and a number of deflections in the signal exceeding a current sensing threshold over a preset period and including means for determining the maximum amplitude of noise over a preset period of time;

wherein the measuring occurs during a period following detected cardiac depolarization; and

(f) adjusting means for adjusting the current sensing threshold dependant upon at least one of the measured amplitude of noise, the measured number of deflections in the signal over a predetermined period, and the measured number of deflections in the signal exceeding the current sensing threshold.

10. The implantable cardiac rhythm management device as recited in claim 9, further including a discriminating means for discriminating the detected deflections from a tachyrhythmia of the patient'"'"'s heart.

11. The implantable cardiac rhythm management device as recited in claim 9, wherein at least one of the amplitude of the noise, the number of deflections in the signal over the predetermined period and the number of deflections in the signal exceeding the current sensing threshold, is measured during a predetermined portion of the period.

12. The implantable cardiac rhythm management device as recited in claim 9, wherein the period is initiated by a detection of cardiac depolarization resulting from an intrinsic event in an atrium of the patient'"'"'s heart.

13. The implantable cardiac rhythm management device as recited in claim 9, wherein the period is initiated by a detection of cardiac depolarization resulting from an intrinsic event in a ventricle of the patient'"'"'s heart.

14. The implantable cardiac rhythm management device as recited in claim 9, further including means for averaging the amplitude of noise over a preset period of time.

15. A method of automatically adjusting a sensing threshold in a cardiac rhythm management device in order to distinguish cardiac depolarization events from noise in a cardiac electrogram signal, the cardiac rhythm management device being of the type having means for sensing intrinsic events, a controller, and means controlled by the controller for applying cardiac stimulation pulses to a patient'"'"'s heart on a beat-to-beat basis, said method including the steps of:

(a) setting the sensing threshold to a predetermined value;

(b) sensing signals comprising electrical impulses corresponding to cardiac depolarization and noise;

(c) detecting from the sensed signal intrinsic cardiac events and noise;

(d) measuring an amplitude of the noise during a period following detected intrinsic cardiac events and storing the measured amplitude of noise over a plurality of detected intrinsic cardiac events;

(e) adjusting the sensing threshold dependant upon the measured amplitude of the noise over the plurality of detected intrinsic cardiac events.

16. The method as recited in claim 15, further including the step of discriminating the detected noise from a tachyrhythmia prior to adjusting the sensing threshold.

17. The method as recited in claim 15, wherein the measurement of the amplitude of noise is initiated by detecting a cardiac depolarization resulting from an intrinsic event in an atrium of the patient'"'"'s heart.

18. The method as recited in claim 15, wherein the measurement of the amplitude of noise is initiated by detecting a cardiac depolarization resulting from an intrinsic event in a ventricle of the patient'"'"'s heart.

19. The method as recited in claim 15, further including the step of storing the measured amplitude of noise over a plurality of detected cardiac depolarizations prior to adjusting the threshold and then adjusting the sensing threshold dependant upon the measured amplitude of noise from prior detected cardiac depolarization.

20. The method as recited in claim 15, wherein the measured amplitudes of noise, measured for the predetermined period of time, are averaged and the average amplitude of noise is used to adjust the sensing threshold.

21. The method as recited in claim 15, wherein the measured amplitudes of noise, measured for the preset period of time, are maximized and the maximum measured amplitude of noise is used to adjust the sensing threshold.